Ownership history in Knott David M Jr · 5 quarters on record
This page tracks every 13F SEC filing in which Knott David M Jr reported a position in Viridian Therapeutics, Inc. (VRDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 145,000 | +28,426 | +24.4% | 2.09% | $4.5M | $31.12 |
| 2025 Q3 | ADDED | 116,574 | +25,091 | +27.4% | 1.01% | $2.5M | $21.58 |
| 2025 Q2 | ADDED | 91,483 | +61,483 | +204.9% | 0.58% | $1.3M | $13.98 |
| 2025 Q1 | ADDED | 30,000 | +5,000 | +20.0% | 0.19% | $404K | $13.48 |
| 2024 Q4 | INITIATED | 25,000 | — | — | 0.17% | $479K | $19.17 |
As of 2025 Q4 — sorted by position size